miRNEST 2.0: an integrative microRNA resource miRNEST 2.0, an integrative microRNA resource :: Browse



Data derived from PhenomiR


PubMed IDdiseasedisease classtissueexpressionfoldchange maxfoldchange mingenesstudy designmethod
18607389 Colorectal cancer - 114500 Cancer colorectum miRNA overexpression - 1.3 - Patient study phenotype-control quantitative PCR
17616669 Prostate cancer - 176807 Cancer prostate gland miRNA overexpression - - - Patient study phenotype-control miRNA microarray
18270258 Medullary thyroid carcinoma - 155240 Cancer thyroid gland miRNA overexpression - 136.4 - Patient study phenotype-control quantitative PCR
17875710 Ovarian cancer - 604370 (Epithelial ovarian cancer, endometrioid histotype - 0) Cancer ovary miRNA downregulation - 2.94118 - Patient study phenotype-control miRNA microarray
17363563 Glioblastoma multiforme, somatic - 137800 Cancer U-251 cell miRNA downregulation - 10.8 - Cell culture study quantitative PCR
18458333 Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) Cancer ovary miRNA downregulation - - - Cell culture study miRNA microarray
18381414 Squamous cell carcinoma, head and neck - 601400 (Oral squamous carcinoma (OSCC) - 0) Cancer HSC-3 cell miRNA downregulation - - - Cell culture study quantitative PCR
18442408 Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) Cancer ovary cancer cell miRNA overexpression - 3.77 - Patient study phenotype-phenotype quantitative PCR
18973228 Medulloblastoma - 155255 Cancer cerebellum miRNA downregulation - 7.14286 - Patient study phenotype-control quantitative PCR
17976522 Myelofibrosis, idiopathic - 254450 Hematological granulocyte miRNA downregulation - 16.6667 - Patient study phenotype-control quantitative PCR
16192569 Breast cancer - 114480 Cancer T-47D cell miRNA downregulation - 1.69492 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer SK-BR-3 cell miRNA downregulation - 1.28205 - Cell culture study quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA overexpression - 42.36 - Patient study phenotype-phenotype quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA downregulation - 5.88235 - Patient study phenotype-phenotype quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA downregulation - 6.66667 - Patient study phenotype-phenotype quantitative PCR
18223217 Hepatocellular carcinoma - 114550 (Hepatocellular carcinoma, associated with hepatitis B/C viral infection and cirrhosis - 0) Cancer liver miRNA overexpression - 2.5 - Patient study phenotype-phenotype quantitative PCR
18223217 Hepatocellular carcinoma - 114550 (Hepatocellular carcinoma, associated with hepatitis B/C viral infection and cirrhosis - 0) Cancer liver miRNA overexpression - 2.5 - Patient study phenotype-control quantitative PCR
18307259 Hepatocellular carcinoma - 114550 (Hepatocellular carcinoma, associated with hepatitis B/C viral infection and cirrhosis - 0) Cancer liver miRNA overexpression - 3.04 - Patient study phenotype-control quantitative PCR
17621267 Cancer - 0 (Cholangiocarcinoma - 0) Cancer KMS-6 cell miRNA downregulation - - - Cell culture study miRNA microarray
16754881 Breast cancer - 114480 Cancer breast epithelium miRNA overexpression - - - Patient study phenotype-control array CGH
16754881 Melanoma and neural system tumor syndrome - 155755 Cancer cell culture miRNA downregulation - - - Cell culture study array CGH
16192569 Breast cancer - 114480 Cancer MCF-7 cell miRNA downregulation - 1.6129 - Cell culture study quantitative PCR
17616669 Prostate cancer - 176807 Cancer PC-3 cell miRNA overexpression - - - Cell culture study miRNA microarray
17761882 Parkinson disease - 168600 Neurological cerebellar cortex miRNA downregulation - 1.26582 - Patient study phenotype-control quantitative PCR
17761882 Parkinson disease - 168600 Neurological cerebellum miRNA overexpression - 4.64 - Patient study phenotype-control quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-231 cell miRNA downregulation - 2.22222 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-361 cell miRNA overexpression - 1.68 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PC-3 cell miRNA downregulation - 2.77778 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PPC-1 cell miRNA downregulation - 4.7619 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer DU-145 cell miRNA downregulation - 2.0 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer Tsu-Pr1 cell miRNA downregulation - 6.66667 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer LNCaP cell miRNA downregulation - 2.08333 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA overexpression - 1.41 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA downregulation - 1.23457 - Cell culture study quantitative PCR
16192569 Pancreatic cancer - 260350 Cancer PANC-1 cell miRNA overexpression - 2.24 - Cell culture study quantitative PCR
16192569 Lung cancer - 211980 Cancer lung cancer cell line miRNA downregulation - 1.47059 - Cell culture study quantitative PCR
16192569 Hematological - 0 Hematological K-562 cell miRNA overexpression - 1.43 - Cell culture study quantitative PCR
18607389 - - embryo miRNA overexpression - 1.56 - Bioprocess study quantitative PCR
16192569 Lung cancer - 211980 Cancer A-549 cell miRNA downregulation - 1.40845 - Cell culture study quantitative PCR
17191223 - - lung miRNA downregulation - - - Bioprocess study quantitative PCR